Close this search box.

Neurological Disorder Companies

U.S. Exchanges

List of Publicly Traded Neurological Disorder Companies Listed on Major U.S. Exchanges

The publicly traded companies on this list are biotech, medical device, pharmaceutical or other healthcare companies that provide products and treatments relating to neurological disorders and diseases. It is very common for companies on this list to provide products and services in other healthcare areas in addition to these areas.


Additional publicly traded healthcare companies and healthcare categories can be accessed through the link below:

List of Publicly Traded Healthcare Companies

A comparison widget that shows trend, earnings per share (EPS), P/E ratio and beta for each of the companies on this list can be accessed through the link below.

Neurological Disorder Industry Comparison Widget

Select the company’s link to access charts, news links and company website and social media information.

Neurological: Mid-Cap Stocks

Ionis Pharmaceuticals, Inc. (IONS) (RNA-targeted drug discovery and development: cancer, cardiovascular, metabolic, neurological disorders, rare diseases)

Neurocrine Biosciences, Inc. (NBIX) (Neurological and endocrine based diseases and disorders)

Penumbra, Inc. (PFN) (IPO in September 2015: Medical devices for strokes and peripheral vascular conditions)

Neurological: Small-Cap Stocks

Acorda Therapeutics, Inc. (ACOR) (Biopharmaceutical company: neurological disorders)

Avexis Inc. (AVXS) (IPO February 11, 2016: Gene therapy company with a focus on rare neurological genetic diseases)

Biohaven Pharmaceutical Holding Company Ltd. (BHVN) (IPO May 4, 2017; biopharmaceutical company: neurological diseases)

Natus Medical Incorporated (BABY) (Medical devices and software: data management systems, hearing screening and diagnostic systems, jaundice management products, neurology diagnostic systems, newborn care products, sleep diagnostics systems)

Vanda Pharmaceuticals Inc. (VNDA) (Biopharmaceutical company: atopic dermatitis, Non-24-Hour Disorder, schizophrenia)

Neurological: Micro-Cap Stocks

Brainstorm Cell Therapeutics Inc. (BCLI) (Stem cell therapies for neurodegenerative diseases)

Catalyst Pharmaceuticals, Inc. (CPRX) (Biopharmaceutical company: rare neuromuscular and neurological diseases)

Edge Therapeutics Inc. (EDGE) (IPO in October 2015: Neurological conditions)

MediciNova, Inc. (MNOV) (Biopharmaceutical company: neurological disorders, treatment of acute exacerbations of asthma)

Ovid Therapeutics Inc. (OVID) (IPO May 5, 2017; biopharmaceutical company: rare neurological disorders)

VTV Therapeutics Inc. (VTVT) (IPO in July 2015: Clinical stage pharmaceutical company: cancer, central nervous system disorders, diabetes and metabolic disorders, inflammation)

Neurological: Nano-Cap Stocks

Cerecor Inc. (CERCU) (IPO in October 2015: Biopharmaceutical company: neurological and psychiatric diseases)

Marinus Pharmaceuticals, Inc. (MRNS) (Biopharmaceutical company: neuropsychiatric therapeutics)

Pernix Therapeutics Holdings, Inc. (PTX) (Specialty, primary care and generic medicines; neurology and pain management)

Prana Biotechnology Ltd. (PRAN) (Australia: neurodegenerative diseases, Alzheimer’s and Huntington diseases)

Related Links:

List of Pharmaceutical Companies

List of Biotech Companies

List of Healthcare ETFs

Publicly Traded Companies by Sector and Industry